Novel therapies in managing Allergic rhinitis: How far have we come? Dr. Kamal Kant Kohli8 Jun 2022 7:15 AM GMTAllergic rhinitis(AR) is a common respiratory condition affecting 40 % of the worldwide population. Due to its shared pathophysiology with...
Respiratory Allergic Affections: Management in India and Therapeutic Effect of Montelukast Dr. Kamal Kant Kohli22 April 2022 4:30 AM GMTAllergic diseases have turned into a major health concern around the world, with India being no exemption. Purportedly, over 25% of the total...
Babies with Low weight with maternal history have increased risk of Allergic rhinitis Dr. Shravani Dali9 April 2022 4:45 AM GMTChildren with early-low and catch-up or below-average BMI growth, along with a mother with allergic rhinitis, have an increased risk for allergic...
Quick Review: Diagnosis and management of allergic rhinitis in clinic Dr. Kamal Kant Kohli9 March 2022 7:00 AM GMTAllergic Rhinitis is one of the common conditions for which medical intervention is sought and is a leading cause of widespread morbidity. At a global...
House dust immunotherapy to be helpful against asthma Dr. Nandita Mohan1 March 2022 2:07 PM GMTAsthma severely affects quality of life, several medications and practices are suggested to treat it. House dust mite sublingual immunotherapy may be...
Review: Intranasal corticosteroids in Allergic rhinitis Dr. Kamal Kant Kohli28 Feb 2022 6:24 AM GMTAllergic Rhinitis is one of the most common persistent conditions for which clinical intervention is sought and is a significant cause of widespread...
Single dose of omalizumab before pollen season beneficial in seasonal allergic rhinitis: Study Dr. Shravani Dali24 Feb 2022 3:30 AM GMTA dose of omalizumab administered before pollen season improved symptom control and quality of life compared with standard medication among patients...
Glenmark Pharma arm secures USFDA nod for Ryaltris nasal spray Ruchika Sharma14 Jan 2022 6:14 AM GMTMumbai: Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned subsidiary Glenmark...
Managing allergic rhinitis and asthma: Analyzing the role of Montelukast-Levocetirizine combination Dr. Kamal Kant Kohli15 Dec 2021 6:27 AM GMTAllergic rhinitis (AR) is now being acknowledged as a global health burden with estimates highlighting that 10%-25% of the population worldwide is...
Montelukast - Preferred Choice in Long Term Management of Respiratory Allergies Dr. Kamal Kant Kohli25 Nov 2021 5:50 AM GMTRespiratory Allergies in India - Unique Challenges & Need for Early Interventions An estimated 300 million people worldwide have asthma, with...
Glenmark gets marketing approval for Ryaltris in 13 EU, UK countries Ruchika Sharma1 Oct 2021 6:11 AM GMTMumbai: Global pharma company, Glenmark Pharmaceuticals Limited, has recently announced that the company has received marketing approval for its...
Allergic rhinitis tied to nasal surgery success in sleep apnea patients, Finds study Dr. Nandita Mohan13 July 2021 3:15 AM GMTNasal obstruction is common in patients with obstructive sleep apnea (OSA). Nonetheless, the effectiveness of isolated nasal surgery in treatment of...
